For High-Risk Prostate Cancer Patients, New Tool Helps Physicians Tailor Hormone Therapy
Sep 30th 2008Drug InformationEndocrinology
Using one of the largest databases of prostate cancer outcomes in the United States, Fox Chase Cancer Center researchers have developed a prediction tool that uses a patient’s clinical information to estimate the benefit of adding androgen deprivation therapy of various durations to radiation therapy.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
